Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE study of long-term efficacy and safety of toludesvenlafaxine hydrochloride extended-release tablets in Chinese patients with major depressive disorder
CTR20241499Phase 4Active
- Sponsor
- Luye Pharma Group
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of toludesvenlafaxine in major depressive disorder (MDD), sponsored by Luye Pharma Group. Started Jun 2024; status: active.
02
Drugs
toludesvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20241499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241499.